201 related articles for article (PubMed ID: 10347231)
1. The ubiquitin-proteasome pathway and serine kinase activity modulate adenomatous polyposis coli protein-mediated regulation of beta-catenin-lymphocyte enhancer-binding factor signaling.
Easwaran V; Song V; Polakis P; Byers S
J Biol Chem; 1999 Jun; 274(23):16641-5. PubMed ID: 10347231
[TBL] [Abstract][Full Text] [Related]
2. Regulation of S33/S37 phosphorylated beta-catenin in normal and transformed cells.
Sadot E; Conacci-Sorrell M; Zhurinsky J; Shnizer D; Lando Z; Zharhary D; Kam Z; Ben-Ze'ev A; Geiger B
J Cell Sci; 2002 Jul; 115(Pt 13):2771-80. PubMed ID: 12077367
[TBL] [Abstract][Full Text] [Related]
3. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex.
Hämmerlein A; Weiske J; Huber O
Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065
[TBL] [Abstract][Full Text] [Related]
4. Signaling through beta-catenin and Lef/Tcf.
Novak A; Dedhar S
Cell Mol Life Sci; 1999 Oct; 56(5-6):523-37. PubMed ID: 11212302
[TBL] [Abstract][Full Text] [Related]
5. Lymphoid enhancer factor-1 blocks adenomatous polyposis coli-mediated nuclear export and degradation of beta-catenin. Regulation by histone deacetylase 1.
Henderson BR; Galea M; Schuechner S; Leung L
J Biol Chem; 2002 Jul; 277(27):24258-64. PubMed ID: 11986304
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor gamma activation can regulate beta-catenin levels via a proteasome-mediated and adenomatous polyposis coli-independent pathway.
Sharma C; Pradeep A; Wong L; Rana A; Rana B
J Biol Chem; 2004 Aug; 279(34):35583-94. PubMed ID: 15190077
[TBL] [Abstract][Full Text] [Related]
7. Differential interaction of plakoglobin and beta-catenin with the ubiquitin-proteasome system.
Sadot E; Simcha I; Iwai K; Ciechanover A; Geiger B; Ben-Ze'ev A
Oncogene; 2000 Apr; 19(16):1992-2001. PubMed ID: 10803460
[TBL] [Abstract][Full Text] [Related]
8. Regulation of lymphoid enhancer factor 1/T-cell factor by mitogen-activated protein kinase-related Nemo-like kinase-dependent phosphorylation in Wnt/beta-catenin signaling.
Ishitani T; Ninomiya-Tsuji J; Matsumoto K
Mol Cell Biol; 2003 Feb; 23(4):1379-89. PubMed ID: 12556497
[TBL] [Abstract][Full Text] [Related]
9. CK2 phosphorylation of the armadillo repeat region of beta-catenin potentiates Wnt signaling.
Song DH; Dominguez I; Mizuno J; Kaut M; Mohr SC; Seldin DC
J Biol Chem; 2003 Jun; 278(26):24018-25. PubMed ID: 12700239
[TBL] [Abstract][Full Text] [Related]
10. Differential nuclear translocation and transactivation potential of beta-catenin and plakoglobin.
Simcha I; Shtutman M; Salomon D; Zhurinsky J; Sadot E; Geiger B; Ben-Ze'ev A
J Cell Biol; 1998 Jun; 141(6):1433-48. PubMed ID: 9628899
[TBL] [Abstract][Full Text] [Related]
11. A yeast model system for functional analysis of beta-catenin signaling.
Lee MS; D'Amour KA; Papkoff J
J Cell Biol; 2002 Sep; 158(6):1067-78. PubMed ID: 12235124
[TBL] [Abstract][Full Text] [Related]
12. Cross-regulation of beta-catenin-LEF/TCF and retinoid signaling pathways.
Easwaran V; Pishvaian M; Salimuddin ; Byers S
Curr Biol; 1999 Dec; 9(23):1415-8. PubMed ID: 10607566
[TBL] [Abstract][Full Text] [Related]
13. Nuclear beta-catenin displays GSK-3beta- and APC-independent proteasome sensitivity in melanoma cells.
Bonvini P; Hwang SG; El-Gamil M; Robbins P; Kim JS; Trepel J; Neckers L
Biochim Biophys Acta; 2000 Feb; 1495(3):308-18. PubMed ID: 10699468
[TBL] [Abstract][Full Text] [Related]
14. Regulation of beta-catenin signaling by the B56 subunit of protein phosphatase 2A.
Seeling JM; Miller JR; Gil R; Moon RT; White R; Virshup DM
Science; 1999 Mar; 283(5410):2089-91. PubMed ID: 10092233
[TBL] [Abstract][Full Text] [Related]
15. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.
Caca K; Kolligs FT; Ji X; Hayes M; Qian J; Yahanda A; Rimm DL; Costa J; Fearon ER
Cell Growth Differ; 1999 Jun; 10(6):369-76. PubMed ID: 10392898
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.
Tan C; Costello P; Sanghera J; Dominguez D; Baulida J; de Herreros AG; Dedhar S
Oncogene; 2001 Jan; 20(1):133-40. PubMed ID: 11244511
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells.
Rahmani M; Read JT; Carthy JM; McDonald PC; Wong BW; Esfandiarei M; Si X; Luo Z; Luo H; Rennie PS; McManus BM
J Biol Chem; 2005 Apr; 280(13):13019-28. PubMed ID: 15668231
[TBL] [Abstract][Full Text] [Related]
18. beta-catenin is a target for the ubiquitin-proteasome pathway.
Aberle H; Bauer A; Stappert J; Kispert A; Kemler R
EMBO J; 1997 Jul; 16(13):3797-804. PubMed ID: 9233789
[TBL] [Abstract][Full Text] [Related]
19. Nuclear endpoint of Wnt signaling: neoplastic transformation induced by transactivating lymphoid-enhancing factor 1.
Aoki M; Hecht A; Kruse U; Kemler R; Vogt PK
Proc Natl Acad Sci U S A; 1999 Jan; 96(1):139-44. PubMed ID: 9874785
[TBL] [Abstract][Full Text] [Related]
20. Complex formation of adenomatous polyposis coli gene product and axin facilitates glycogen synthase kinase-3 beta-dependent phosphorylation of beta-catenin and down-regulates beta-catenin.
Hinoi T; Yamamoto H; Kishida M; Takada S; Kishida S; Kikuchi A
J Biol Chem; 2000 Nov; 275(44):34399-406. PubMed ID: 10906131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
